Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, we analyzed responses to mRNA vaccination against COVID-19 among these patients…
Go to article Click Here
JAK inhibitors Transcript
So, we've been working on this class of drugs [JAK inhibitors] now for about 5 or 6 years, both in our research...